Biocon Biologics Profile
Key Indicators
- Authorised Capital ₹ 3,507.50 Cr
as on 05-07-2024
- Paid Up Capital ₹ 1,321.70 Cr
as on 05-07-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20,781.03 Cr
as on 05-07-2024
- Satisfied Charges ₹ 100.00 Cr
as on 05-07-2024
- Revenue 21.86%
(FY 2022)
- Profit -58.99%
(FY 2022)
- Ebitda -7.01%
(FY 2022)
- Net Worth 3.48%
(FY 2022)
- Total Assets 7.46%
(FY 2022)
About Biocon Biologics
The Corporate was formerly known as Biocon Biologics India Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3,507.50 Cr and a paid-up capital of Rs 1,321.70 Cr.
The company currently has active open charges totaling ₹20,781.03 Cr. The company has closed loans amounting to ₹100.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biocon Biologics Limited India are Shreehas Tambe as Ceo, Mr Upadhye as Cfo, and Deepika Srivastava as Company Secretary. Nivruti Rai, Thomas Roberts, Nicholas Haggar, and Eight other members serve as directors at the Company.
- CIN/LLPIN
U24119KA2016PLC093936
- Company No.
093936
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2016
- Date of AGM
28 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biocon Biologics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreehas Tambe  | CEO | 05-Dec-2022 | Current |
| Mr Upadhye | CFO | Current | |
| Deepika Srivastava | Company Secretary | 14-Feb-2023 | Current |
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nivruti Rai  | Director | 01-Aug-2019 | Current |
| Kiran Shaw | Whole-Time Director | 08-Jun-2016 | Current |
| Daniel Bradbury | Director | 01-Aug-2019 | Current |
| Bobby Parikh | Director | 01-Aug-2019 | Current |
| Thomas Roberts | Director | 15-Nov-2021 | Current |
Nicholas Haggar  | Additional Director | 25-Mar-2024 | Current |
Financial Performance and Corporate Structure Insights of Biocon Biologics.
Biocon Biologics Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.86% increase. The company also saw a substantial fall in profitability, with a 58.99% decrease in profit. The company's net worth moved up by a moderate rise of 3.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biocon Biologics?
In 2023, Biocon Biologics had a promoter holding of 92.04% and a public holding of 7.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Schneider Electric India Private LimitedActive 29 years 9 monthsDeepika Srivastava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 06 Mar 2023 | ₹9,841.76 Cr | Open |
Others Creation Date: 03 Mar 2023 | ₹9,841.76 Cr | Open |
Others Creation Date: 13 Sep 2021 | ₹200.00 Cr | Open |
How Many Employees Work at Biocon Biologics?
Biocon Biologics has a workforce of 5280 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biocon Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
